Literature DB >> 25091736

Senescent stroma promotes prostate cancer progression: the role of miR-210.

Maria Letizia Taddei1, Lorenzo Cavallini2, Giuseppina Comito2, Elisa Giannoni2, Marco Folini3, Alberto Marini4, Paolo Gandellini3, Andrea Morandi2, Gianfranco Pintus4, Maria Rosaria Raspollini5, Nadia Zaffaroni3, Paola Chiarugi6.   

Abstract

We focused our interest on senescent human-derived fibroblasts in the progression of prostate cancer. Hypoxic senescent fibroblasts promote prostate cancer aggressiveness by inducing epithelial to mesenchymal transition (EMT) and by secreting energy-rich compounds to support cancer cell growth. Hypoxic senescent fibroblasts additionally increase: i) the recruitment of monocytes and their M2-macrophage polarization, ii) the recruitment of bone marrow-derived endothelial precursor cells, facilitating their vasculogenic ability and iii) capillary morphogenesis, proliferation and invasion of human mature endothelial cells. In addition, we highlight that overexpression of the hypoxia-induced miR-210 in young fibroblasts increases their senescence-associated features and converts them into cancer associated fibroblast (CAF)-like cells, able to promote cancer cells EMT, to support angiogenesis and to recruit endothelial precursor cells and monocytes/macrophages.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Prostate cancer; Senescence; Tumor microenvironment; miR-210

Mesh:

Substances:

Year:  2014        PMID: 25091736      PMCID: PMC5528604          DOI: 10.1016/j.molonc.2014.07.009

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  60 in total

Review 1.  The age of cancer.

Authors:  R A DePinho
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

2.  Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.

Authors:  Gerold Untergasser; Roland Gander; Claudia Lilg; Günter Lepperdinger; Eugen Plas; Peter Berger
Journal:  Mech Ageing Dev       Date:  2005-01       Impact factor: 5.432

3.  Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent.

Authors:  V V Ogryzko; T H Hirai; V R Russanova; D A Barbie; B H Howard
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

4.  Epithelial-mesenchymal transition induced by senescent fibroblasts.

Authors:  Remi-Martin Laberge; Pierre Awad; Judith Campisi; Pierre-Yves Desprez
Journal:  Cancer Microenviron       Date:  2011-06-25

5.  Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation.

Authors:  Simona Parrinello; Jean-Philippe Coppe; Ana Krtolica; Judith Campisi
Journal:  J Cell Sci       Date:  2005-01-18       Impact factor: 5.285

Review 6.  EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy.

Authors:  Elisa Giannoni; Matteo Parri; Paola Chiarugi
Journal:  Antioxid Redox Signal       Date:  2011-11-02       Impact factor: 8.401

7.  Serum interleukin 6 as a prognostic factor in patients with prostate cancer.

Authors:  J Nakashima; M Tachibana; Y Horiguchi; M Oya; T Ohigashi; H Asakura; M Murai
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

8.  EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts.

Authors:  Elisa Giannoni; Maria Letizia Taddei; Matteo Parri; Francesca Bianchini; Michela Santosuosso; Renata Grifantini; Gabriella Fibbi; Benedetta Mazzanti; Lido Calorini; Paola Chiarugi
Journal:  J Mol Med (Berl)       Date:  2012-08-19       Impact factor: 4.599

9.  Senescent stroma promotes prostate cancer progression: the role of miR-210.

Authors:  Maria Letizia Taddei; Lorenzo Cavallini; Giuseppina Comito; Elisa Giannoni; Marco Folini; Alberto Marini; Paolo Gandellini; Andrea Morandi; Gianfranco Pintus; Maria Rosaria Raspollini; Nadia Zaffaroni; Paola Chiarugi
Journal:  Mol Oncol       Date:  2014-07-21       Impact factor: 6.603

10.  Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.

Authors:  Marialuisa Bocchino; Savina Agnese; Evelina Fagone; Silvia Svegliati; Domenico Grieco; Carlo Vancheri; Armando Gabrielli; Alessandro Sanduzzi; Enrico V Avvedimento
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

View more
  46 in total

1.  The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer.

Authors:  Isabelle Bar; Ahmad Merhi; Fadi Abdel-Sater; Abduelhakem Ben Addi; Sara Sollennita; Jean-Luc Canon; Paul Delrée
Journal:  J Histochem Cytochem       Date:  2017-04-12       Impact factor: 2.479

2.  miR-210, a modulator of hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cell.

Authors:  Lu Ding; Le Zhao; Wei Chen; Ting Liu; Zhen Li; Xu Li
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 3.  Cellular senescence in renal ageing and disease.

Authors:  Ines Sturmlechner; Matej Durik; Cynthia J Sieben; Darren J Baker; Jan M van Deursen
Journal:  Nat Rev Nephrol       Date:  2016-12-28       Impact factor: 28.314

4.  DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.

Authors:  C Pistore; E Giannoni; T Colangelo; F Rizzo; E Magnani; L Muccillo; G Giurato; M Mancini; S Rizzo; M Riccardi; N Sahnane; V Del Vescovo; K Kishore; M Mandruzzato; F Macchi; M Pelizzola; M A Denti; D Furlan; A Weisz; V Colantuoni; P Chiarugi; I M Bonapace
Journal:  Oncogene       Date:  2017-06-05       Impact factor: 9.867

Review 5.  miRNAs derived from cancer-associated fibroblasts in colorectal cancer.

Authors:  Amir Savardashtaki; Zahra Shabaninejad; Ahmad Movahedpour; Roxana Sahebnasagh; Hamed Mirzaei; Michael R Hamblin
Journal:  Epigenomics       Date:  2019-11-08       Impact factor: 4.778

6.  The interplay of growth differentiation factor 15 (GDF15) expression and M2 macrophages during prostate carcinogenesis.

Authors:  Sudha M Sadasivan; Yalei Chen; Nilesh S Gupta; Xiaoxia Han; Kevin R Bobbitt; Dhananjay A Chitale; Sean R Williamson; Andrew G Rundle; Deliang Tang; Benjamin A Rybicki
Journal:  Carcinogenesis       Date:  2020-08-12       Impact factor: 4.944

Review 7.  Hypoxia driven glycation: Mechanisms and therapeutic opportunities.

Authors:  Mohammad Imran Khan; Suvasmita Rath; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Semin Cancer Biol       Date:  2017-05-22       Impact factor: 15.707

Review 8.  The functional multipotency of transforming growth factor β signaling at the intersection of senescence and cancer.

Authors:  Justyna Mikuła-Pietrasik; Szymon Rutecki; Krzysztof Książek
Journal:  Cell Mol Life Sci       Date:  2022-03-19       Impact factor: 9.261

9.  Senescent stroma promotes prostate cancer progression: the role of miR-210.

Authors:  Maria Letizia Taddei; Lorenzo Cavallini; Giuseppina Comito; Elisa Giannoni; Marco Folini; Alberto Marini; Paolo Gandellini; Andrea Morandi; Gianfranco Pintus; Maria Rosaria Raspollini; Nadia Zaffaroni; Paola Chiarugi
Journal:  Mol Oncol       Date:  2014-07-21       Impact factor: 6.603

Review 10.  Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches.

Authors:  Valentina Doldi; Marzia Pennati; Barbara Forte; Paolo Gandellini; Nadia Zaffaroni
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.